Jump to page content

Application period: November 3rd, 2025 to January 16th, 2026

Focus on: Start-ups and late-stage academic projects in the field of gene- and cell-based innovations

Definition: 

International gene- and cell-based therapies (GCT) are defined here as the following methods, among others:

  • Therapeutic approaches with advanced therapy medicinal products (ATMPs):
    • Somatic cell therapeutics (for example in the form of stem cells, immune system cells or mesenchymal stromal cells, among others)
    • Gene therapeutics in the form of substitution, addition or suppression therapies using viral and non-viral vectors or genome editing
    • Tissue engineering products such as the production of tissues for surgical use, including the use of novel biomaterials
  • Therapeutic approaches with novel biological products, such as mRNA- and other nucleic acid-based methods, extracellular vesicles or exosomes
  • Companion diagnostics for advanced therapies
  • Oncolytic virus-based therapies, which employ genetically engineered or naturally occurring viruses to selectively infect and destroy tumor cells while stimulating systemic anti-tumor immunity
  • Bacteria-based therapeutics, making use of naturally occurring or engineered bacteria (e.g. Clostridium, Salmonella) for targeted tumor colonization, local delivery of therapeutic agents, and immune modulation
  • Integration of artificial intelligence (AI) along the GCT value chain, e.g. in:
    • the discovery and optimization of therapeutic targets and vectors,
    • predictive modeling of patient responses and therapy outcomes,
    • automation and quality control in cell and tissue manufacturing,
    • analysis of multi-omics data for personalized treatment strategies.

Benefits:

  • Participate and pitch at GeneNovate Investors' Day on June 9, 2026.
  • Connect with relevant key investors and industry leaders.
  • Benefit from expert selectionby a jury comprising academic representatives, public and private investors.
  • Enhance your presentation with mandatory pitch training in April/May 2026.
  • Travel support: We will take care of your accommodation and cover the travel costs for one participating person.

Take advantage of this unique opportunity to showcase your innovative ideas and accelerate your journey in the field of gene and cell-based therapies!

Start your application today!